Fundraising FoxKhanu
Venture capitalDortmund · Pre-Seed–Seed · 7 people tracked
Find your way into Khanu
Sign up to see every warm intro you have to Khanu
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Khanu team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
KHAN is an early-stage life sciences venture fund focused on translating academic research into commercially viable drug assets. It partners cooperatively with academic innovators across Europe (EU/Horizon 2020 countries), targeting first-in-class therapies for markets with high unmet medical need, remaining indication- and modality-agnostic. KHAN acts as an active facilitator/incubator, not requiring a fully validated asset, filed patent, legal entity, or complete team. It helps structure projects, build companies, and advance innovations toward patients while sourcing assets through its incubation ecosystem, notably a partnership with the Lead Discovery Center. Investments span proof of concept through pre-seed and seed stages, including validated targets, drug candidate nomination, IND filing, and first-in-man studies.
Source: firm website, verified Sep 27, 2026.
Team · 7 people
from the firm's website
What they invest in
from 8 of 11 portfolio companiesBiotech ×5Deep Tech ×4Impact & Social Good ×3Healthtech ×2AI & Machine Learning ×1Cleantech ×1Climate Tech ×1Digital Health ×1
HQs:Austria×2Germany×2European Union×1
Investments · 11 tracked
founders shown can be your intro pathThis is a page describing "Industrielle Schlüsseltechnologien – Leitbetriebe 2030," a grant funding program from Austria's aws (Austria Wirtschaftsservice) that provides non-repayable grants of up to 3 million euros for projects in strategic future fields such as AI, advanced production technologies, new materials, energy and environmental technologies, and aviation and mobility.
Deep TechGovTechImpact & Social GoodSaaS
The European Investment Fund is a multilateral development bank with AAA credit ratings that provides capital and financing to foster economic impact through its strong balance sheet and governance.
CleantechClimate TechEnergyEnterprise SoftwareFintechImpact & Social GoodLuxembourg, EU
Co-investorsAlpine Space VenturesBOMCrowberry CapitalInvivo Capital PartnersM80 PartnersTesi (Finnish Industry Investment Ltd)+2 more
CasInvent Pharma develops pharmaceutical solutions, currently raising Series A funding through a crowdfunding campaign.
BiotechHealthtech
Alexander Scheer(CEO)in
Co-investorsBiotech Investments S.R.Oi&i Biotech FundJIC Ventures
Cutanos is a biotechnology company developing a Langerhans Cell Targeted Delivery System (LC-TDS) that uses a langerin-specific glycomimetic ligand to direct lipid nanoparticle and mRNA/protein formulations to specific skin-resident dendritic cells for vaccines and immunotherapies.
BiotechDeep TechHealthtechVienna, AT
Christoph Rademacher(Co-Founder & Advisor)inRobert Wawrzinek(Co-Founder & Advisor (former CEO))Timm-H. Jessen(Interim CEO / Managing Director)Ulrich Platte(CFO & CBO)
Co-investorsxista science ventures
EVL Bio is developing a selective anti-FGFR4 monoclonal antibody therapy to treat left ventricular hypertrophy (LVH) in patients with chronic kidney disease (CKD).
BiotechDigital HealthLongevity
Robert Kirmeier(Founder)inWenzel von der Heydte(CEO & Co-founder)inThomas Kirmeier(COO & Co-founder)
Co-investorsAdBio partnersKurma PartnersBoehringer Ingelheim Venture Fund
KHAN is a drug discovery investment company that finances and translates early-stage academic science into pharmaceutical products, retaining IP rights on the projects it funds.
BiotechDeep Tech
Co-investorsEuropean Investment Fund
KyDo Therapeutics is a preclinical-stage biotechnology company developing novel covalent-allosteric small molecule inhibitors intended to become best-in-class oncology drugs.
AI & Machine LearningBiotechDortmund, DE
Co-investorsi&i Biotech Fund
The Max Planck Foundation is a German charitable foundation, established in 2006 by private donors, that channels private funding to basic research at the institutes of the Max Planck Society.
Deep TechImpact & Social Good
Co-investorsBayern KapitalDeepTech & Climate Fonds
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
KinSeaLead Discovery CenterNodus Oncology
Portfolio news
latest coverage across their companiesKyDo Therapeutics · tu-dortmund.de · Sep 17, 2025
Frequently asked questions
- How many investments has Khanu made?
- Khanu has 11 tracked investments.
- What stage does Khanu invest at?
- Khanu invests at the Pre-Seed, Seed stages.
- What sectors does Khanu focus on?
- Khanu focuses on Biotech, Deep Tech, Healthtech, Medical Devices.
- Where is Khanu located?
- Khanu is headquartered in Dortmund, DE.
- Who does Khanu co-invest with?
- Khanu most often shares deals with i&i Biotech Fund, Alpine Space Ventures, BOM, among 13 tracked co-investors.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Connecticut Innovations is the state of Connecticut's venture capital arm, providing financing and ongoing strategic support to innovative, growing companies based in Connecticut.